AUTHOR=Fatima Naheed , Cohen Devin C., Sukumar Gauthaman , Sissung Tristan M., Schooley James F., Haigney Mark C., Claycomb William C., Cox Rachel T., Dalgard Clifton L., Bates Susan E., Flagg Thomas P. TITLE=Histone deacetylase inhibitors modulate KATP subunit transcription in HL-1 cardiomyocytes through effects on cholesterol homeostasis JOURNAL=Frontiers in Pharmacology VOLUME=6 YEAR=2015 URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2015.00168 DOI=10.3389/fphar.2015.00168 ISSN=1663-9812 ABSTRACT=
Histone deacetylase inhibitors (HDIs) are under investigation for the treatment of a number of human health problems. HDIs have proven therapeutic value in refractory cases of cutaneous T-cell lymphoma. Electrocardiographic ST segment morphological changes associated with HDIs were observed during development. Because ST segment morphology is typically linked to changes in ATP sensitive potassium (KATP) channel activity, we tested the hypothesis that HDIs affect cardiac KATP channel subunit expression. Two different HDIs, romidepsin and trichostatin A, caused ~20-fold increase in SUR2 (